Assessment of Anticancer properties of Artemisia sieberi and its active substance: an in vitro study
-
Zohreh Abdolmaleki
,
Hossein-Ali Arab
,
Saeid Amanpour
,
Farrokh Tirgari
,
Kamran Mansouri
,
Samad Muhammadnejad
Abstract
Background: Artemisinin and its derivatives are well known as anti-malaria drugs and particularly useful for the treatment of infection of Plasmodium falciparum malaria parasites. In recent years, there are many reports of anticancer activities of artemisinins both in vitro and in vivo. This study aimed to investigate the cytotoxicity and anti-angiogenic activity of the ethanolic extract of Artemisia sieberi (EEA) in comparison to its active substance, artemisinin (ART).Methods: The cytotoxic effects of EEA and ART on the HCT-116 colorectal adenocarcinoma cells line were studied by clonogenic assay.The inhibitory effect of test compounds on angiogenesis was evaluated by three-dimensional culture cells model on human umbilical vein endothelial cells (HUVECs) in cytodex-3-microcarriers as in vitro model.Results: The results showed that EEA significantly started inhibition of colony-forming capacity of HCT-116 cells line at concentrations of 1 up to 100µg/ml (P < 0.001). We also found EEA and ART markedly reduced the angiogenic activities on HUVECs culture in a concentration-dependent fashion (P < 0.001, r = 0.997 and P< 0.001, r = 0.998 respectively).Conclusion: It seems that EEA has high cytotoxic effect on HCT-116 cells line and also it is a potent inhibitor of angiogenesis in cultured cells. These results provide the primary findings for further investigations on therapeutic or preventive properties of Artemisia sieberi on cancer.Li Q, Peggins JO, Fleckenstein LL, Masonic, K, Heiffer MH, Brewer TG. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol. 1998;(50):173-182.
Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1, Curr Oncol 2006;(13):14-26.
Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;(18):767-73.
Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol. 2003;(64):382-94.
Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug targets. 2006;(7):407-21.
Lai H, Nakase I, Lacoste E, Singh NP, Sasaki T. Artemisinin–transferring conjugate retards growth of breast tumors in the rat. Anticancer Res. 2009;(29):3807–3810.
Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, et al. Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett. 2009;(274):290–298.
Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin. Cancer Res. 2008;(14):5519–5530.
Li Q, Hickman M. Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins. Toxicol. 2011;(279):1-9.
Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anti-cancer drug. J Biomed Biotechnol. 2012;(2012):2475-97.
Chen H.H, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res. 2003;(48):231-6.
Schmidt C. Why do tumors become resistant to antiangiogenesis drugs?. J Nati Cancer Inst. 2009;(101):1530-2.
Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;(8):579-91.
Podlech D. Artemisia. In: Rechinger, K.H. (Ed.), Flora Iranica, Flora des Iranischen Hochlandes und der umrahmenden Gebirge, Graz, Akademische Druck- und Verlagsanstalt, Austria, 1986;(158):159–223.
Arab HA, Rahbari S, Rassouli A, Moslemi MH, Khosravirad F. Determination of artemisinin in Artemisia sieberi and anticoccidial effects of the plant extract in broiler chickens. Trop Anim Health Prod. 2006;(38):497-503.
Arab HA, Mardjanmehr SH, Shahbazfar A, Rassouli A, Abdollahi M, Nekouie O. Toxicopathologic Effects of Artemisinin in Broiler Chickens Following a Single Oral Dose: An LD 50 Study. Int J Poultry Sci. 2009;(8):808–812.
Franken NA, Rodermond HM, Stap J,Haveman J, vanBree C. Clonogenic assay of cells in vitro. Nat Protoc, 2006;(1):2315-2319.
Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res. 1995;(50):311-22.
Griffith CK, Miller C, Sainson RC, et al. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 2005;(11);257-66.
Weifeng T, Feng S, Xiangji L, Changqing S, Zhiquan Q, Huazhong Z, et al. Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine. 2011;(18):158-62.
Firestone GL, Sundar SN. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med. 2009;(1):e32.
Chen HH, Zhou HJ, Wang WQ, Wu GD. Antimalarial dihydroartemisinin also inhibits angiogenesis. Cancer Chemother Pharmacol. 2004a;(53):423-32.
Chen HH, Zhou HJ, Wu GD, Lou XE. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacol. 2004b;(71):1-9.
Oh S, Jeong IH, Ahn CM, Shin WS, Lee S. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives. Bioorg Med Chem. 2004;(12):3783-90.
Huan-huan C, Li-Li Y, Shang-Bin L. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell. Cancer lett. 2004;(211):163-73.
Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 2001;(17),122-6.
Galal AM, Ross SA, ElSohly MA, El-Feraly FS, Ahmed MS, McPhail AT. Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation. J Nat Prod. 2002;(65):184-8.
| Files | ||
| Issue | Vol 7 No 1 (2015) | |
| Section | Original Articles | |
| Keywords | ||
| Cytotoxicity Anti-angiogenesis Human umbilical endothelial cells Artemisinin Ethanolic extract of Artemisia sieberi | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
